← Back to Search

Device

Intervention for Type 2 Diabetes

N/A
Waitlist Available
Research Sponsored by Abbott Diabetes Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six (6) months
Awards & highlights

Study Summary

This trial will compare the weight-loss effects of the FreeStyle Libre 2 system to the current standard of care for diabetes monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six (6) months
This trial's timeline: 3 weeks for screening, Varies for treatment, and six (6) months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in bodyweight from the control arm at 6 months

Trial Design

2Treatment groups
Active Control
Group I: Standard of CareActive Control1 Intervention
No intervention will be administered. Subjects randomized to the Standard of Care Arm will continue using their Current standard of care device to monitor and manage their diabetes
Group II: InterventionActive Control1 Intervention
Subjects randomized to this Arm will use FreeStyle Libre 2 to monitor and manage their diabetes.

Find a Location

Who is running the clinical trial?

Abbott Diabetes CareLead Sponsor
63 Previous Clinical Trials
24,726 Total Patients Enrolled
Shridhara A Karinka, PhDStudy DirectorAbbott Diabetes Care
9 Previous Clinical Trials
2,748 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~13 spots leftby Apr 2025